Effect of homologous or heterologous vaccine booster over two initial doses of inactivated COVID-19 vaccine
Introduction Inactivated vaccines were delivered to low- and middle-income countries during the early pandemics of COVID-19. Currently, more than 10 inactivated COVID-19 vaccines have been developed. Most inactivated vaccines contain an inactivated whole-cell index SARS-CoV-2 strain that is adjuvant...
Saved in:
Main Authors: | Viravarn Luvira, Punnee Pitisuttithum |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2024-12-01
|
Series: | Expert Review of Vaccines |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/14760584.2024.2320861 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Homologous or heterologous administration of mRNA or adenovirus-vectored vaccines show comparable immunogenicity and effectiveness against the SARS-CoV-2 Omicron variant
by: Gabiria Pastore, et al.
Published: (2024-12-01) -
Immune and Safety Analysis of <i>ultra</i>IPV<sup>TM</sup>, a Novel UVC-Inactivated Polio Vaccine
by: David A. MacLeod, et al.
Published: (2025-06-01) -
Immune memory reactivation and T cell dynamics following 12-month homologous CoronaVac booster: a longitudinal cohort study
by: Xinran Song, et al.
Published: (2025-07-01) -
Inactivated recombinant influenza vaccine: the promising direction for the next generation of influenza vaccine
by: Hua Shi, et al.
Published: (2024-12-01) -
Isolation and identification of Mycoplasma synoviae in Hebei, China, and evaluation of the immune protection efficacy of inactivated vaccines
by: Zhuanzhuan Wang, et al.
Published: (2025-09-01)